Concepedia

Gongxin Liu

GL

Statistics

Publications

6

Citations

381

H-Index

6

Active since

2012

Affiliations

Gilead Sciences (United States)(Current)

Gilead Sciences (United Kingdom)

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo

Hadassah Medical Center

Harvard University

Gongxin Liu is an author at Gilead Sciences (United States) specializing in pharmacology, cardiology, and antiarrhythmic therapy.

Publications per year

2012–2016

6

Publications

6

A Novel, Potent, and Selective Inhibitor of Cardiac Late Sodium Current Suppresses Experimental Arrhythmias

Luiz Belardinelli, Gongxin Liu, Cathy Smith-Maxwell et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 190 citations

, , +17

If inhibition in the atrioventricular node by ivabradine causes rate-dependent slowing of conduction and reduces ventricular rate during atrial fibrillation

Richard L. Verrier, Rodolfo Bonatti, Ana F. G. Silva et al. · Heart Rhythm · 2014 · 72 citations

, , +17

Combined Actions of Ivabradine and Ranolazine Reduce Ventricular Rate During Atrial Fibrillation

Richard L. Verrier, Ana F. G. Silva, Rodolfo Bonatti et al. · Journal of Cardiovascular Electrophysiology · 2014 · 39 citations

, , +17

The novel late Na<sup>+</sup> current inhibitor, GS‐6615 (eleclazine) and its anti‐arrhythmic effects in rabbit isolated heart preparations

Sridharan Rajamani, Gongxin Liu, Nesrine El‐Bizri et al. · British Journal of Pharmacology · 2016 · 34 citations · Full text

, , +17

Discovery of Dihydrobenzoxazepinone (GS-6615) Late Sodium Current Inhibitor (Late <i>I</i><sub>Na</sub>i), a Phase II Agent with Demonstrated Preclinical Anti-Ischemic and Antiarrhythmic Properties

Jeff Zablocki, Elfatih Elzein, Xiaofen Li et al. · Journal of Medicinal Chemistry · 2016 · 34 citations · Full text

, , +17

1–5 of 6